All Categories
  • All Categories
  • Accessories
  • Accessories & More
  • Butters & Eggs
  • Camera & Video
  • Mornitors
  • Tablets
  • Laptops
  • Handbags
  • Headphone & Speaker
  • Herbs & botanicals
  • Vegetables
  • Shop
  • Laptops & Desktops
  • Watchs
  • Electronic

Amlodipine Impurity 4

SZ CAT No SZ-A005016
CAS No 103094-30-0
Mol.F. C25H34ClNO6
Mol.Wt. 480.0
Inv. Status Custom Synthesis


Chemical Name: 3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-(2,2-diethoxy-ethoxymethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate; 3-ETHYL-5-METHYL-4-(2-CHLOROPHENYL)-2-(2,2-DIETHOXY-ETHOXYMETHYL)-6-METHYL-1,4-DIHYDRO-PYRIDINE-3,5-DICARBOXYLATE;3-ETHYL-5-METHYL-4-(2-CHLOROPHENYL)-2-(2,2-DIETHOXY-ETHOXYMETHYL)-6-METHYL-1,4-DIHYDRO-PYRIDINE-3,5-DIDARBOXYLATE;3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-Ethoxymethyl)-6-Methyl-1,4-Dihydro-Pyridine-3,5-Dicarboxylate;3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-Ethoxymethyl)-6-Methyl-1,4-Dihydro-Pyridine-3,5-Didarboxylate;4-92-ChloroPhenyl)-3-EthoxyCarbonyl-5-MethoxyCarbonyl-6-Methyl-2-(2-PhthalimidoEthoxy)Methyl-1,4-DihydroPyridine,AmlodipineBesylate;4-(2-Chloro Phenyl)-3-Ethoxycarbonyl-5-Methoxy carbonyl-6-Methyl-2- (2-Phthalimido Ethoxy) Methyl-1,4-Dihydro Pyridine

Smiles: O=C(C(C(C(C=CC=C1)=C1Cl)C(C(OC)=O)=C(C)N2)=C2COCCN(C3=O)C(C4=C3C=CC=C4)=O)OCC

Inchi: InChI=1S/C20H18N2O/c1-15-13-16(2)22-20(21-15)23-14-19(17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-14H,1-2H3

Identification and characterization of potential impurities of amlodipine maleate
P. Sudhakar a, M. Nirmala a, J. Moses Babu a,∗, K. Vyas a, Ganta Madhusudan Reddy b, B. Vijaya Bhaskar b, P. Pratap Reddy b, K. Mukkanti c
J. Braz. Chem. Soc., Vol. 19, No. 1, 35-41, 2008.
 
Determination of the Absolute Configuration of the Active Amlodipine Enantiomer as (-)-S: A Correction
Siegfried Goldmann,* Jiirgen Stoltefuss, and Liborius Born
J. Med. Chem. 1992,35,3341-3344
 
Development of a Stability-Indicating HPLC Method for Simultaneous Determination of Amlodipine Besylate and Atorvastatin Calcium in Bulk and Pharmaceutical Dosage Form
Hafez HM*, Elshanawany AA, Abdelaziz LM and Mohram MS
Hafez et al., Pharm Anal Acta 2014, 5:9